Literature DB >> 23868475

Lessons learned from the CDC's Colorectal Cancer Screening Demonstration Program.

Laura C Seeff1, Elizabeth A Rohan.   

Abstract

This report briefly summarizes 13 articles in this dedicated supplement to Cancer documenting the full implementation and evaluation of CDC's Colorectal Cancer Screening Demonstration Program (CRCSDP). The supplement includes 3 articles that describe clinical and quality outcomes; 2 articles that describe programmatic and clinical costs; 3 that were based on a multiple case study, using qualitative methods to describe the overall implementation experience of this initiative; and 4 articles written by and about individual program sites. The comprehensive, multi-methods evaluation conducted alongside the program produced many important lessons regarding the design, start-up, and implementation of colorectal cancer screening in this high-need population, and paved the way for the CDC to establish a larger, population-based colorectal cancer control initiative, broadly aligned with expectations of the Patient Protection and Affordable Care Act through its population-based emphasis on using a health systems approach to increase colorectal cancer screening. Cancer 2013;119(15 suppl):2817-9.
© 2013 American Cancer Society. © 2013 American Cancer Society.

Entities:  

Keywords:  cancer screening programs; colonoscopy; colorectal cancer prevention; colorectal cancer screening; fecal occult blood testing

Mesh:

Year:  2013        PMID: 23868475     DOI: 10.1002/cncr.28165

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  8 in total

1.  Costs of colorectal cancer screening provision in CDC's Colorectal Cancer Control Program: Comparisons of colonoscopy and FOBT/FIT based screening.

Authors:  Sujha Subramanian; Florence K L Tangka; Sonja Hoover; Janet Royalty; Amy DeGroff; Djenaba Joseph
Journal:  Eval Program Plann       Date:  2017-02-07

2.  A culturally and linguistically salient pilot intervention to promote colorectal cancer screening among Latinos receiving care in a Federally Qualified Health Center.

Authors:  Clement K Gwede; Steven K Sutton; Enmanuel A Chavarria; Liliana Gutierrez; Rania Abdulla; Shannon M Christy; Diana Lopez; Julian Sanchez; Cathy D Meade
Journal:  Health Educ Res       Date:  2019-06-01

3.  The Impact of Massachusetts Health Reform on Colorectal and Breast Cancer Stage at Diagnosis.

Authors:  Lindsay M Sabik; Kirsten Y Eom; Bassam Dahman; Jie Li; Nengliang Yao; G J van Londen; Cathy J Bradley
Journal:  Med Care       Date:  2020-02       Impact factor: 2.983

4.  Patients' perceptions of colorectal cancer screening tests and preparatory education in federally qualified health centers.

Authors:  Clement K Gwede; Alexis M Koskan; Gwendolyn P Quinn; Stacy N Davis; Jamila Ealey; Rania Abdulla; Susan T Vadaparampil; Gloria Elliott; Diana Lopez; David Shibata; Richard G Roetzheim; Cathy D Meade
Journal:  J Cancer Educ       Date:  2015-06       Impact factor: 2.037

5.  Providers' knowledge, attitudes, and practices related to colorectal cancer control in Brazil.

Authors:  Douglas M Puricelli Perin; Mona Saraiya; Trevor D Thompson; Lenildo de Moura; Eduardo J Simoes; Diana C Parra; Ross C Brownson
Journal:  Prev Med       Date:  2015-10-09       Impact factor: 4.018

6.  The impact of preventive screening resource distribution on geographic and population-based disparities in colorectal cancer in Mississippi.

Authors:  Fazlay S Faruque; Xu Zhang; Elizabeth N Nichols; Denae L Bradley; Royce Reeves-Darby; Vonda Reeves-Darby; Roy J Duhé
Journal:  BMC Res Notes       Date:  2015-09-08

7.  The CDC Colorectal Cancer Control Program, 2009-2015.

Authors:  Djenaba A Joseph; Amy DeGroff
Journal:  Prev Chronic Dis       Date:  2019-12-05       Impact factor: 2.830

8.  Regional Differences in Colorectal Cancer Mortality Between 2000 and 2013 in Republic of Korea.

Authors:  Hyeong Taek Woo; Jin Ah Sim; Jonghoon Mo; Young Ho Yun; Aesun Shin
Journal:  J Epidemiol       Date:  2018-10-06       Impact factor: 3.211

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.